Back to Search
Start Over
[Molecular mechanism of tissue-specific actions of SERM].
- Source :
-
Clinical calcium [Clin Calcium] 2006 Sep; Vol. 16 (9), pp. 1469-74. - Publication Year :
- 2006
-
Abstract
- Selective estrogen receptor modulator (SERM) is designated as synthetic ligands for estrogen receptors (ERs), exhibiting tissue-specific agonisitic/antagonisitic activities. Among SERM, raloxifen is a most clinically successful as an anti-oseteoporotic agent. Such tissue-specific actions of SERM are presumed to mediate through unusual structure alteration of liganded ERs coupled with co-regulator recruitments.
- Subjects :
- Bone Density Conservation Agents adverse effects
Bone Density Conservation Agents therapeutic use
Female
Humans
Organ Specificity
Osteoporosis
Raloxifene Hydrochloride adverse effects
Raloxifene Hydrochloride therapeutic use
Receptors, Estrogen chemistry
Receptors, Estrogen genetics
Receptors, Estrogen physiology
Selective Estrogen Receptor Modulators adverse effects
Selective Estrogen Receptor Modulators therapeutic use
Transcription, Genetic
Bone Density Conservation Agents pharmacology
Raloxifene Hydrochloride pharmacology
Selective Estrogen Receptor Modulators pharmacology
Subjects
Details
- Language :
- Japanese
- ISSN :
- 0917-5857
- Volume :
- 16
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Clinical calcium
- Publication Type :
- Academic Journal
- Accession number :
- 16951470
- Full Text :
- https://doi.org/CliCa060914691474